8102
-
Biologics: Targets and Therapy
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Real benefits for authors, including fast-track processing of papers.
Biologics: Targets and Therapy
(1,101,182) Views
Editor in Chief Dr Doris Mangiaracina Benbrook
1177-5475
ReviewComplexing proteins in botulinum toxin type A drugs: a help or a hindrance?
Jürgen Frevert, Dirk Dressler
Biologics: Targets and Therapy 2010, 4:325-332
09 December 2010
Review
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
Tariq I Mughal, Andrew Schrieber
Biologics: Targets and Therapy 2010, 4:315-323
02 December 2010
Review
Gaucher disease: clinical profile and therapeutic developments
Timothy M Cox
Biologics: Targets and Therapy 2010, 4:299-313
06 December 2010
Review
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
William Boland, Gwyn Bebb
Biologics: Targets and Therapy 2010, 4:289-298
09 November 2010
Review
Proteasome inhibition and its therapeutic potential in multiple myeloma
Ajai Chari, Amitabha Mazumder, Sundar Jagannath
Biologics: Targets and Therapy 2010, 4:273-287
28 September 2010
Review
New and emerging treatment approaches to lupus
Marion Haubitz
Biologics: Targets and Therapy 2010, 4:263-271
06 September 2010
Original Research
Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes
Darja Kanduc
Biologics: Targets and Therapy 2010, 4:245-261
09 September 2010
Review
Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer
Jaclyn Flanigan, Hari Deshpande, Scott Gettinger
Biologics: Targets and Therapy 2010, 4:237-243
26 August 2010
Review
New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride
Cary O Harding
Biologics: Targets and Therapy 2010, 4:231-236
06 August 2010
Review
Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines
Aruna Chandran, Sean Fitzwater, Anjie Zhen, et al
Biologics: Targets and Therapy 2010, 4:213-229
30 July 2010
Review
Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent
Peter Reimer, Rolf Vosshenrich
Biologics: Targets and Therapy 2010, 4:199-212
04 August 2010
Review
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
Peter E Clark
Biologics: Targets and Therapy 2010, 4:187-197
28 June 2010
Review
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
Mohamedtaki A Tejani, Roger B Cohen, Ranee Mehra
Biologics: Targets and Therapy 2010, 4:173-185
28 June 2010
Original Research
Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies
Yuan Li, Janine A Burns, Carol A Cheney, et al
Biologics: Targets and Therapy 2010, 4:163-171
15 June 2010
Review
Decreasing glioma recurrence through adjuvant cancer stem cell inhibition
Josh Neman, Rahul Jandial
Biologics: Targets and Therapy 2010, 4:157-162
22 June 2010
Review
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
J Paul Frindik, Stephen F Kemp
Biologics: Targets and Therapy 2010, 4:147-155
09 June 2010
Review
Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle
Andreas Rank, Oliver Weigert, Helmut Ostermann
Biologics: Targets and Therapy 2010, 4:139-145
24 May 2010
Review
Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
Ori Toker, Philip J Hashkes
Biologics: Targets and Therapy 2010, 4:131-138
17 May 2010
Review
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
Santo Raffaele Mercuri, Luigi Naldi
Biologics: Targets and Therapy 2010, 4:119-129
10 May 2010
Review
Use of clofarabine for acute childhood leukemia
A Pession, R Masetti, K Kleinschmidt, et al
Biologics: Targets and Therapy 2010, 4:111-118
24 June 2010
Review
Palliative treatment of malignant ascites: profile of catumaxomab
Lila Ammouri, Eric E Prommer
Biologics: Targets and Therapy 2010, 4:103-110
14 May 2010
Review
Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib
Chris Coppin
Biologics: Targets and Therapy 2010, 4:91-101
30 April 2010
Review
Management of patients with advanced non-small cell lung cancer: role of gefitinib
Vamsidhar Velcheti, Daniel Morgensztern, Ramaswamy Govindan
Biologics: Targets and Therapy 2010, 4:83-90
19 April 2010
Original Research
Hepatitis B virus and Homo sapiens proteomewide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins
Rosalia Ricco, Darja Kanduc
Biologics: Targets and Therapy 2010, 4:75-81
01 April 2010
Original Research
Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model
Brent Sorenson, Kaysie Banton, Lance Augustin, et al
Biologics: Targets and Therapy 2010, 4:61-73
16 March 2010
Review
Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency
Sabine Kroiss, Manuela Albisetti
Biologics: Targets and Therapy 2010, 4:51-60
09 March 2010
Review
Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
Mohamed Mahdi-Rogers, Yusuf A Rajabally
Biologics: Targets and Therapy 2010, 4:45-49
09 March 2010
Original Research
A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis
Stephen P Myers, Joan O’Connor, J Helen Fitton, et al.
Biologics: Targets and Therapy 2010, 4:33-44
12 February 2010
Review
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
Richard Quek, Suzanne George
Biologics: Targets and Therapy 2010, 4:19-31
03 February 2010
Review
Recombinant follitropin alfa/lutropin alfa in fertility treatment
Ahmed Gibreel, Siladitya Bhattacharya
Biologics: Targets and Therapy 2010, 4:5-17
22 December 2009
Original Research
Safety of etanercept in elderly subjects with rheumatoid arthritis
Alfredomaria Lurati, Mariagrazia Marrazza, Katia Angela, et al
Biologics: Targets and Therapy 2010, 4:1-4
22 December 2009
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed
